title: Prostate cancer epigenome.
abstract: Prostate cancer is a major health burden within the ever-increasingly aging US population. The molecular mechanisms involved in prostate cancer are diverse and heterogeneous. In this context, epigenetic changes, both global and gene specific, are now an emerging alternate mechanism in disease initiation and progression. The three major risk factors in prostate cancer: age, geographic ancestry, and environment are all influenced by epigenetics and additional significant insight is required to gain an understanding of the underlying mechanisms. The androgen receptor and its downstream effector pathways, central to prostate cancer initiation and progression, are subject to a multitude of epigenetic alterations. In this review we focus on the global perspective of epigenetics and the use of recent next-generation sequencing platforms to interrogate epigenetic changes in the prostate cancer genome.
authors.affiliation: Center for Cancer Research and Therapeutic Development, Clark Atlanta University, 223 James P. Brawley Dr. SW, Atlanta, GA, 30314, USA.
authors.forename: Swathi
authors.initials: S
authors.lastname: Chinaranagari
authors.forename: Pankaj
authors.initials: P
authors.lastname: Sharma
authors.forename: Nathan J
authors.initials: NJ
authors.lastname: Bowen
authors.forename: Jaideep
authors.initials: J
authors.lastname: Chaudhary
mesh_terms: D057890:Epigenomics / Q000379:methods*; D056426:Genetic Loci / Q000235:genetics; D000076983:Histone Methyltransferases; D011495:Histone-Lysine N-Methyltransferase / Q000378:metabolism; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D011944:Receptors, Androgen / Q000378:metabolism
chemical_list: D011944:Receptors, Androgen; D000076983:Histone Methyltransferases; D011495:Histone-Lysine N-Methyltransferase